IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies
NCT07574346
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Malignancies
Interventions
DRUG:
IASO207 Injection
Sponsor
Peking University People's Hospital